Early detection of breast cancer is an important public health policy. Programs of regular screening examinations have been widely established in an attempt to detect the disease when the primary tumour diameter is small. In South Australia, BreastScreen SA suggests that women between the ages of 50 and 70 years be screened every 24 months.
Introduction
Breast cancer remains a severe health risk. In South Australia a woman has an estimated lifetime chance of 1 in 13 of developing the disease, and this chance is doubled or tripled if there have been cases of breast cancer in close relatives.
The prognosis at first detection involves many factors, including the size of the primary tumour, the disease stage, the tumour histology, the age and general health of the woman.
However, the main methods of detection involve the primary breast tumour, the size of which is now regarded as a prime single predictor of the future course of the disease.
There is a large body of literature concerning this issue spread over an extended period of time; for example, Fisher, Slack & Bross (1969) ; Duncan & Kerr (1976) ; Zurrida et al (1999) . Detection programs attempt to find primary tumours early, before they have spread to local lymph glands, and beyond. Such programs carried out on a regular basis are referred to as "screening", with an individual set of examinations being called a "screen".
The principles of early detection have changed very little over the years. The present mechanics of screening women is, apart from technological advances in radiography, essentially the same as that used in the first major randomised clinical trial testing the effectiveness of regularly screening female populations for breast cancer. This trial was established in New York City in 1963, and it was known as the HIP (Hospital Insurance Plan) Study. Conclusions based on this trial, and others, have been summarised in a review paper by the US Department of Health and Human Services entitled "Screening for Breast Cancer" (USDHHS, (1996) ). It was in the analyses of the results of such studies that technically challenging problems were discovered.
It is intuitive that screen detected disease is generally at an earlier stage than "naturally reported" disease. The difference between the average age of breast cancer patients whose disease is self detected and the average age at which they would have had the tumour detected under a screening program is called the lead-time. Lead-time for breast cancer is of the order of six to eighteen months and it must be taken into account in survival analyses following any trial to avoid systematic biases.
With regard to screening recommendations, these too have not altered greatly over recent years. It is strongly advised to screen women between the ages of 50 years and 70 years every 24 months using mammography, clinical breast examination and breast selfexamination as a joint detection modality. It is unclear whether women outside this age range benefit significantly from screening every 24 months. Nevertheless, women of any age who are thought to be at a higher risk of getting breast cancer due to its presence in close relatives are advised to enrol in an early detection program.
It is reported in USDHHS (loc cit) that screening appears to lead to a reduction in breast cancer mortality of at least 22%. However, this criterion of assessing the impact of a screening program has recently been criticised; Black, Haggstrom & Welch (2002) ; Tabar et al (2002) ; Juffs & Tannock (2002) . We believe that a more useful and direct interpretation of the benefits of breast cancer screening for a woman who is considering entering a program is in terms of the extra lifetime that she may gain. Hence, all our results in this paper are expressed in terms of additional survival time past the age at reporting. We note that survival times have also been used by Jansen & Zoetelief (1995) .
In 1989 BreastScreen SA was established to join a National Programme of Early Detection of Breast Cancer. The South Australian affiliate services a total population of about 142,000 women aged between 50 years and 70 years. Annually between 60,000 and 70,000 screens are carried out, providing a screening service with a screening interval of 24 months (Robinson et al (1996) ).
The main aim of this paper is to demonstrate the possibility of evaluating the impact of a screening service using only data from the service itself, and additional data from the local population-based cancer registry. Our population consists of the women in South Australia and the criterion of evaluation is in terms of additional life-time past the age at which breast cancer was first diagnosed. No data external to South Australia has been used in our evaluation, thus eliminating the concerns of bias due to population mismatch.
We emphasise that the models developed in this paper are specifically designed for the data that has been routinely collected in South Australia. It is not anticipated that these models will necessarily be useful elsewhere. The results reported here are the culmination of efforts spanning some 30 years and we believe this to be an original way to assess the effect on survival of early detection of breast cancer.
In brief, Section 2 is a glossary of acronyms, notation and definitions. In Section 3, we establish the method of estimating median additional survival time following the detection of a primary tumour which is the measure we use to assess the advantages of early detection. Section 4 demonstrates the survival advantages of early detection and quantifies the achievement of BreastScreen SA. Section 5 consists of a technical description of breast cancer screening, develops procedures for some necessary modelling and estimation processes, and extrapolates the results of Section 4. Section 6 summarises the findings of this paper and discusses potential biases in the estimation of survival time.
Notation, definitions and data sets
This section is designed to help readers by defining terms and important acronyms here for quick reference, and describing the various data sets used in this paper.
1. a; the age in years at which a primary breast tumour is first detected.
2. x; the diameter in centimetres of the tumour reported at a.
m(a,x)
; the median additional survival time in years of a woman at a with x. A fitted Cox proportional hazards model, , specified in Section 3 is used to calculate values for m (a,x) . The survival time of a woman past a is a random quantity with a mean that cannot be accurately estimated from our current data sets. 
Estimation of median survival time
In this section we consider the estimation of median survival time in some detail, since this is the measure by which we assess the performance of screening designs of the type currently practiced in South Australia. It is also the measure that we use to quantify the advantages of alternate screening designs.
Breast cancer survival data is available for two distinct but generally comparable populations. The primary data used for survival analysis is the SACR conditioned data (see 2.9). A Cox proportional hazards model was fitted to these survival data, and linear, quadratic and interaction terms for a and x were investigated. Full diagnostic checks for proportionality led to a model with linear and interaction terms for a and x. Influence plots confirmed that there were no data points with undue influence. Scaled Schoenfeld residual plots for the interaction model show no departures from proportionality.
The adequacy of calculating median survival time from this specific parameterization of the Cox model fitted to the SACR conditioned data is illustrated in The agreement between each pair of median survival times, actuarial and ˆ( , ) m a x , is assessed by a z-score. It can be seen in Table 1 that only one z-score is greater than 1 in absolute value. By squaring and summing these z-scores, we get an approximate and perhaps conservative 2 2 χ =2.42, with P = .30. Thus we believe that calculated from the fitted Cox model adequately represents median survival time in the SACR conditioned data over these ranges of a and x.
ˆ( , ) m a x
The survival distributions of the SACR conditioned data and the SEER data (see 2.11)
were examined by using actuarial survival curves, and the results of these comparisons are shown in Table 2 , conditioned on the diameter groupings used in Table 1 . In order to make the survival times from the two data sets comparable, the survival times in the SACR conditioned data were re-coded so that deaths recorded after 12 years became censorings at 12 years. The result of accumulating the probabilities from the five diameter groups by using the Fisher method is with P=.62; Cox & Hinkley, (1974) . Two summary statistics, the 75 th percentile and the survival after 11 years S(11), are also shown in Table 2 to illustrate the magnitude of the differences in survival between the two groups. The conclusion is that overall survival, and survival conditioned on diameter, is not materially nor demonstrably different in the two data sets matched on a and x, but not on other factors which may influence survival. It was reassuring that the Australian and American breast cancer survival experiences showed a close agreement, which was anticipated a priori, since a substantial divergence would have lead to an uncomfortable inferential impasse. We have compared the survival distributions determined from the SACR conditioned data against the SEER data because of the critical role that estimated median survival time plays in our assessments of screening designs. Nevertheless, it must be noted that, since the survival distributions can only be compared over 12 years, the power of discrimination may be weak and for reasons previously stated, the two groups cannot be regarded as absolutely exchangeable. (see 2.11) 
Survival advantage of early detection of breast cancer

An illustration
In order to illustrate the effect of early detection on survival, consider the example of a woman with a tumour which remains undetected until it reaches x=3 by a=65, with . This combination of a, x and is used as a benchmark in this section, with a and x being a reasonable approximation to the historical average reporting age and diameter of the SACR diameter data (see 2.8).
Suppose that the tumour was discovered at a less than 65 when x=1. For the present purposes we take β =.07, determined later in Section 5. Applying the model for tumour growth x(t; β ) (see 2.5) it is easily found that x=1 when a = 63.7, and consequently (63.7,1) = 19.2 m . With a 1 = 63.7, x 1 = 1 and a 2 = 65, x 2 = 3, then G = 7.1 (see 2. 4).
Similarly, if the tumour was detected at x = 2, or x = 4 or x = 5, the same argument gives values of G as 3. Cady (1997) .
A woman having the average detection age and tumour diameter of the BSSA data (see 2.10) has (60.9,1.65)=19.79 (1.11), where the estimated standard error in parentheses has been calculated by using bootstrap techniques with 1000 repeated samplings; Efron & Tibshirani (1993 result. In the following sections we develop a structural framework and statistical estimates required to investigate the effect on G of reducing the screening interval from 24 to 12 months, and of beginning screening at 40 rather than 50 years of age.
Definitions of components for the screening process
It is straightforward to heuristically review the broadest aspects of screening. For example, suppose a woman enters a screening program at the age of 50 years. She has been continuously subjected to the risk of initiating a breast tumour during the previous 30 years or so. There are three possible outcomes for a woman entering the screening program with an undetected tumour. She could have the tumour detected by screening, she could self-detect the tumour between screens, or she could die before the tumour is detected in either way. These events are assumed to be dictated largely by the rate of initiating tumours, tumour size and rate of growth, the sensitivity of the screening procedure for detecting tumours, and the likelihood of the woman finding and reporting the disease herself in the presence of the competing risk of natural mortality. If a tumour of a particular size is found, then the patient's survival prospects will depend on, at the very least, the age of the woman and the size of the tumour.
In this way we identify six basic components which must be known in order to develop a basic understanding and quantification of screening. These components are
(1) The probability of surviving to a for South Australian women, S(a);
(2) The probability of self-detecting a primary tumour less than x, P(x);
(3) The probability of detecting a primary tumour of diameter x when subjected to screening, r(x);
(4) The distribution of growth rates, β , of primary tumours, ; ( ) b β (5) The probability of a woman ever contracting breast cancer, ; in the absence of natural mortality, and given that the woman contracts the disease, the probability of initiating the disease by age y, H(y). 
A model for breast cancer incidence
The SACR incidence data (see 2.12) is shown in Table 3 with the frequency distribution denoted as a I . To derive a tailored and credible model to simulate the distribution of a I is a detailed and subtle process. However, here we restrict the derivation to a discussion of the mean of a I and a brief outline of distributional properties.
Given a woman does contract the disease, let A be the age at which the woman first detects a primary breast tumour, the age at reporting for short. Clearly, A is a random variable, and we let Pr (A=a) = f(a), These contributions are generated from a multinomial with 61 probabilities, γf(a)S(a), and, since the number of women in the 1937 cohort is large, the random variables generated by the multinomial, in the limit, are distributed as independent Poisson variables. The same is true for all cohorts who contribute to the 1977-92 incidence years. Similarly, we let the discrete pdf of Y be Table 3 , taking into account the form of P(t). This analysis suggested that the pdf of H(y) had a sigmoid shape and this particular property of the data is necessarily reflected in our parameterised by differentiating P with respect to x, and evaluated using the SACR diameter data. The likelihood parameter estimates and standard errors are given in Table 4 . The estimates and conform to the results reported by Kusama et al (loc cit) .
It should be noted that the breast cancer cases defining are a subset of the cases defining . Since a and x are essentially independently distributed (see Tallis et 
A computer model for screening in South Australia
The six breast cancer screening components detailed in Section 5.1, which have been estimated using South Australian data, have been incorporated into a computer model of the screening process specifically for South Australia. We examine the consequences of both reducing the screening interval from 24 months to 12 months, and beginning screening at 40 rather than 50. There is an extensive literature of mathematical modelling and computer simulation of breast cancer screening processes, some of the earliest being Knox (1973) , Schwartz (1978) The logical structure of the model is briefly outlined, using the notation of the six components discussed in Section 5.1. A cohort of (computer generated) women is progressively aged from birth with the cohort continuously subjected to natural mortality specified by S(a). Tumours are initiated at each age y according to and , with a growth rate assigned to these tumours according toγˆ( An initial basic assessment of the performance of the model was made by specifying a design that accumulates self-reported cases over all ages without involving screening.
The results for this design, labelled Model-unscreened, are shown in Table 5 . Equivalent observed values from a SACR 1997-99 report are also shown in 
Applications of the computer screening model
We firstly consider what might have been achieved had BreastScreen SA used a 12 month screening interval rather than a 24 month interval. This is calculated using the design labelled Model-12. The results are compared to those for Model-24 with the values of G shown in Table 6 . We estimate that there may have been a marginal advantage in using a 12 month screening interval. The results presented in Table 6 are based on the current average screening exposure time of approximately 7 years. We now use the model to estimate the advantages of long term screening. In Table 7 , results are shown using the model with the self-reporting function . The model is specified for an unscreened population over the age of 50, and for screening designs beginning at age 50, with 24 and 12 month screening intervals. The model with a 24 month screening interval is compared to the model for an unscreened population, and the model with a 12 month screening interval is compared to the model P with a 24 month screening interval. For illustration, the parameters defining have been modified to produce a variation in self-reporting, , which has an average value of 2.
This change approximates the self-reported diameter of Cady (loc cit), substantially lowers the benchmark and thereby reduces the possible effect of screening, as previously discussed in Section 4.2. Corresponding results are produced for as for . There are a number of issues that arise from Table 7 .
• The value of G=3.6 achieved for and a 24 month screening interval agrees reasonably well with G=2.9 (.68) calculated for BreastScreen SA in Section 4.2.
The value of P a from BSSA data is about 6 years less than a of the model. This occurs because BreastScreen SA currently has a period of observation of twelve years whereas the design setting summarises a cohort screened every 24 months after fifty.
• The results using suggest that there is an additional survival advantage of 1.5 years for a screening program with a 12 month screening interval when compared to a program with a 24 month interval. This agrees with the value of 1.25 shown for Model-12 in Table 6 . P
• The results using parallel those found for , but to a lesser amount, again emphasising the role that the benchmark plays in these assessments.
*
PP
We use our model to generate results equivalent to those shown in Table 7 , but using 40 rather than 50 as the age of initial screening. The corresponding values of G are 3.41 (0.78) and 1.69 (0.68), which are essentially the same as those shown in Table 7 .
A prominent question in the breast cancer screening literature concerns the efficacy of beginning screening at the age of 40 rather than 50, the currently accepted age at which screening programs start ; USDHHS (loc cit). 
Discussion and Summary
We believe that we have achieved the main aims of this project as outlined in the Introduction. A random sample of women who reported with breast cancer during the period 1980-86 defined the SACR diameter data. This set specified the reporting age a, the diameter of the primary tumour x, and the survival time and status of the patient at the end of 2002. With this information we were able to restrict a and x to form the SACR conditioned data which was used to develop a Cox proportional hazard model with covariates a and x from which we estimated the median additional survival time after reporting, . Using this quantity, we provided in Section 4.1 some simple illustrations of the effect on survival of early detection of the disease, and introduced the concept of benchmark from which early and late detection can be measured and assessed in terms of additional survival time. Screening data from BreastScreen SA was evaluated in Section 4.2. It was found that the reduction in primary tumour diameter at detection due to the screening program produces an estimated gain in median survival time of ( , ) m a x about three years. This estimate is encouraging, but perhaps a more conservative way of interpreting it is to use the standard error to conclude that the gain should be at least 1.5
years. Further, to put these results into perspective, the benchmark median survival represents a loss of 6 years when compared to normal median survival. It appears that under screening, about 3 of these years are recovered.
The interval between screens in the BreastScreen SA program is 24 months and the target We have identified two potential sources of bias which could influence estimates of median survival time. The first is a registry problem. Inevitably some cases are lost to follow-up, thereby leading to over-estimates of median survival time, Tallis et al (1988) .
Fortunately, this is not a major issue in a professionally run registry such as the SACR but, in any case, since we use the difference between two median estimates, any small biases would tend to negate each other.
The second source of bias is less obvious and more technical. An unscreened population such as that leading to the SACR conditioned data is in a steady state. In terms of x, the population is a mixture of two different growth rates, 1 β and 2 β , but, conditionally on β , the cdf of x is invariant, see Tallis et al (loc cit) . Screening changes this steady state by detecting the disease at considerably smaller diameters. It can be shown that when a screened population is referred to a steady state, unscreened population for an estimate of survival time based on a and x, an over-estimate of perhaps half a year can be anticipated.
We have examined both types of bias in detail and conclude that together, they should amount to less than .5 years. In view of the size of the standard errors, and keeping in mind that the historical data of 1980-86 may underestimate the survival experiences of [1990] [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] , no attempt at any correction has been made.
